ERS Genomics Licenses CRISPR-Cas9 Patents to Charles River Laboratories – GenomeWeb
EPM Magazine |
ERS Genomics Licenses CRISPR-Cas9 Patents to Charles River Laboratories
GenomeWeb NEW YORK (GenomeWeb) – ERS Genomics said today that it has signed a non-exclusive license agreement for its CRISPR-Cas9 patents with Charles River Laboratories. Charles River, which uses CRISPR-Cas9 for target screening and to create custom knock-in … Charles River Adds ERS License to CRISPR/Cas9 Service Offering … Horizon Discovery and ERS Genomics expand CRISPR licence rights |
